| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +40.00% | +4.52% | -1.47% | +5.99% | +9.63% | — |
| 14d | 5 | +40.00% | +1.50% | -1.78% | +3.28% | +4.06% | — |
| 30d | 5 | +0.00% | +15.10% | +6.26% | +8.84% | +12.78% | — |
| 60d | 5 | +40.00% | -0.11% | +11.60% | -11.71% | -10.04% | — |
| 90d | 5 | +100.00% | -9.48% | +12.70% | -22.19% | -21.52% | — |
| 180d | 5(5 pending) | — | — | — | — | — | — |
| 1y | 5(5 pending) | — | — | — | — | — | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 139 | $31.79 | $4.4K | 10,306 | Mar 18, 2026 | Mar 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 30 | $32.85 | $986 | 10,276 | Mar 18, 2026 | Mar 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 1,762 | $31.28 | $55.1K | 10,445 | Mar 18, 2026 | Mar 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 1,033 | $32.74 | $33.8K | 12,955 | Mar 17, 2026 | Mar 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 748 | $33.38 | $25.0K | 12,207 | Mar 17, 2026 | Mar 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE Chief Patient Officer | 10,000 | — | — | 30,000 | Mar 15, 2026 | Mar 17, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE Chief Patient Officer | 10,000 | — | — | 13,988 | Mar 15, 2026 | Mar 17, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 48,000 | — | — | 48,000 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |